ANI Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
599.19 |
791.51 |
849.87 |
908.35 |
944.64 |
988.05 |
| Przychód Δ r/r |
0.00% |
32.10% |
7.37% |
6.88% |
4.00% |
4.59% |
| Przychód (min) |
597.59 |
768.23 |
820.46 |
908.34 |
920.21 |
962.49 |
| Przychód (max) |
600.49 |
806.56 |
881.66 |
908.36 |
971.32 |
1,015.95 |
| EBITDA (średnia) |
75.66 |
99.95 |
107.32 |
114.70 |
119.28 |
124.76 |
| EBIT (średnia) |
-25.71 |
-33.96 |
-36.46 |
-38.97 |
-40.53 |
-42.39 |
| EBIT % |
-4.29% |
-4.29% |
-4.29% |
-4.29% |
-4.29% |
-4.29% |
| Zysk netto (średni) |
96.43 |
126.17 |
135.79 |
149.79 |
160.44 |
175.50 |
| Zysk netto % |
16.09% |
15.94% |
15.98% |
16.49% |
16.98% |
17.76% |
| EPS (średnia) |
5.01 |
6.53 |
6.96 |
7.74 |
8.30 |
9.09 |
| Liczba analityków (Przychody) |
5 |
6 |
8 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
3 |
5 |
5 |
1 |
1 |
1 |
| symbol |
ANIP |
ANIP |
ANIP |
ANIP |
ANIP |
ANIP |